Researchers link GLP1 agonists to depression risk in some users and call for personalized prescribing based on genetic ...

"With the FDA announcing the resolution of shortages for Semaglutide (Wegovy, Ozempic) and Tirzepatide (Zepbound, Mounjaro), compounding pharmacies must halt production of these medications. This ...

Initially developed to manage blood sugar levels in diabetic patients, GLP-1 agonists have gained popularity for their weight ...

Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...

New study finds potential link between GLP1 agonists and depression, urging further investigation into patient safety.

The pharma giant said its oral GLP-1 drug demonstrated significant efficacy results and a safety profile consistent with its ...

The drugmaker Lilly announced topline results of a clinical trial of a new pill in the same drug class as injectables like ...

Eli Lilly and Co. aired positive top-line data from the phase III trial called Achieve-1 testing orforglipron vs. placebo in adults with type 2 diabetes and inadequate glycemic control with diet and ...

The drug, orforglipron, helped people with diabetes reduce their blood sugar levels while spurring significant weight loss, ...

Patients on the new pill also lost weight — up to 16 pounds without reaching a plateau at the study’s end. Side effects were ...

Lizard venom has played a crucial part in helping humans take a bite out of diabetes and obesity. The Gila monster is a large, magnificent and venomous desert-dwelling reptile found throughout the ...